Research and Markets (http://www.researchandmarkets.com/research/sngbht/global_molecular)
has announced the addition of the "Global
Molecular Diagnostics Market 2012-2016" report to their
The analysts forecast the Global Molecular Diagnostics market to grow at
a CAGR of 11.42 percent over the period 2012-2016. One of the key
factors contributing to this market growth is the increasing investments
in genomics and proteomics research. The Global Molecular Diagnostics
market has also been witnessing a growth in the diagnostics segment.
However, the compliance with regulatory requirements could pose a
challenge to the growth of this market.
Key vendors dominating this space include Abbott Laboratories, Becton,
Dickinson and Co., QIAGEN N.V., and Roche Holding Ltd.
Other vendors mentioned in the report are Affymetrix nc., Agilent
Technologies Inc., Alere Inc., AmniSure International LLC, Anadys
Pharmaceuticals Inc., Bayer HealthCare AG, Biocartis SA, bioMerieux SA,
Bio-Rad Laboratories Inc., Biotest AG, Carmel Pharma AB, Celera
Diagnostics LLC, Cellestis Ltd., Cepheid Inc., Cytometers Inc., Danaher
Corp., Diagenode SA, Eli Lilly and Co., Eurogentec S.A., Evotec AG, GE
Healthcare Ltd., Genomic Health Inc., Gen-Probe Inc., Illumina Inc.,
Instrumentation Laboratory Co., IRIS International Inc., Janssen Biotech
Inc., KIESTRA Lab Automation BV, Life Technologies Corp., Luminex Corp.,
Merck and Co. Inc., mtm laboratories AG, Nanosphere Inc., Novartis AG,
PerkinElmer Inc., Pharmacyclics Inc., PVT Probenverteiltechnik GmbH,
Quest Diagnostics Inc., Quidel Corp., Safety Syringes Inc., SANYO North
America Corp., Siemens Healthcare, Sirigen Group Limited, St. Jude
Medical Inc., Sysmex Corp., and Thermo Fisher Scientific Inc.
Commenting on the report, an analyst from the Healthcare team said: 'The
Global Molecular Diagnostics market presents several growth
opportunities to vendors. Different vendors in the market are
increasingly forming strategic alliances with pharmaceutical companies
for the development of companion diagnostics, which helps in producing
more effective drugs.
For instance, in February 2013, Abbott Laboratories collaborated with
Janssen Biotech Inc. and Pharmacyclics Inc. to discover the benefits of
Abbott's exclusive FISH technology for use in developing a molecular
companion diagnostic test to identify patients with chronic lymphocytic
For more information visit http://www.researchandmarkets.com/research/sngbht/global_molecular
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To NFVZone's Homepage ]